Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Los

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Infusional Chemotherapy|January 1, 1996
Platinum dose-intensityG Los
Stem Cells (Dayton, Ohio)|May 1, 1993
Platinum resistance: laboratory findings and clinical implicationsF M Muggia, G Los
Cancer Surveys|January 1, 1993
Pharmacokinetic principles of locoregional chemotherapyD J Kerr, G Los
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Experimental and clinical status of intraperitoneal chemotherapyG Los, J G McVie
Hematology/Oncology Clinics of North America|April 1, 1994
Platinum resistance. Experimental and clinical statusG Los, F M Muggia
Meditsina Truda I Promyshlennaia Ekologiia|August 27, 2002
[Hygienic features of work conditions in kinescope assembling, ways of morbidity prophylaxis]I G Los', V D Boldyrev
Cancer Chemotherapy and Pharmacology|March 11, 1999
Expression of GADD153 in tumor cells and stromal cells from xenografted tumors in nude mice treated with cisplatin: correlations with cisplatin-DNA adductsA Johnsson, C Strand, G Los
Experimental Cell Research|October 1, 1981
Cytochalasin B disrupts the association of filamentous web and plasma membrane in hepatocytesD A Mesland, G Los, H Spiele
British Journal of Cancer|July 1, 1991
Antitumour response and nephrotoxicity following intraperitoneal administration of a slow release formulation of cisplatin to rats bearing cancers restricted to the peritoneal cavityG Los, W Kop, M J Deurloo
Journal of Protein Chemistry|April 20, 2001
Recombinant derivatives of clostridial neurotoxins as delivery vehicles for proteins and small organic moleculesM V Zdanovskaia, G Los, A G Zdanovsky
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Infusional Chemotherapy|January 1, 1996
Platinum dose-intensityG Los
Stem Cells (Dayton, Ohio)|May 1, 1993
Platinum resistance: laboratory findings and clinical implicationsF M Muggia, G Los
Cancer Surveys|January 1, 1993
Pharmacokinetic principles of locoregional chemotherapyD J Kerr, G Los
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Experimental and clinical status of intraperitoneal chemotherapyG Los, J G McVie
Hematology/Oncology Clinics of North America|April 1, 1994
Platinum resistance. Experimental and clinical statusG Los, F M Muggia
Meditsina Truda I Promyshlennaia Ekologiia|August 27, 2002
[Hygienic features of work conditions in kinescope assembling, ways of morbidity prophylaxis]I G Los', V D Boldyrev
Cancer Chemotherapy and Pharmacology|March 11, 1999
Expression of GADD153 in tumor cells and stromal cells from xenografted tumors in nude mice treated with cisplatin: correlations with cisplatin-DNA adductsA Johnsson, C Strand, G Los
Experimental Cell Research|October 1, 1981
Cytochalasin B disrupts the association of filamentous web and plasma membrane in hepatocytesD A Mesland, G Los, H Spiele
British Journal of Cancer|July 1, 1991
Antitumour response and nephrotoxicity following intraperitoneal administration of a slow release formulation of cisplatin to rats bearing cancers restricted to the peritoneal cavityG Los, W Kop, M J Deurloo
Journal of Protein Chemistry|April 20, 2001
Recombinant derivatives of clostridial neurotoxins as delivery vehicles for proteins and small organic moleculesM V Zdanovskaia, G Los, A G Zdanovsky
Pageof 7